Anhui Anke BioTech Group (300009) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Anhui Anke BioTech Group (300009) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥240.51 Million ≈ $35.19 Million USD) by net assets (CN¥4.34 Billion ≈ $635.81 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Anhui Anke BioTech Group - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Anhui Anke BioTech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Anhui Anke BioTech Group (300009) total liabilities for a breakdown of total debt and financial obligations.

Anhui Anke BioTech Group Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Anke BioTech Group ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Union Semiconductor (Hefei) Co. Ltd. A SHG:688403	N/A
Hubei TKD Crystal Electn SHG:603738	0.015x
Zhejiang Zhongjian Technology Co Ltd SHE:002779	-0.035x
Leedarson IoT Technology Inc SHG:605365	-0.025x
Affle (India) Limited NSE:AFFLE	0.056x
Shanghai Hanbell Precise Machinery Co Ltd SHE:002158	0.046x
Forvia SE PA:FRVIA	0.228x
Arion banki hf IC:ARION	-0.025x

Annual Cash Flow Conversion Efficiency for Anhui Anke BioTech Group (2006–2024)

The table below shows the annual cash flow conversion efficiency of Anhui Anke BioTech Group from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Anhui Anke BioTech Group (300009) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.30 Billion ≈ $629.22 Million	CN¥685.37 Million ≈ $100.29 Million	0.159x	-36.37%
2023-12-31	CN¥3.93 Billion ≈ $575.42 Million	CN¥985.01 Million ≈ $144.14 Million	0.250x	+21.91%
2022-12-31	CN¥3.40 Billion ≈ $497.78 Million	CN¥698.98 Million ≈ $102.28 Million	0.205x	+0.75%
2021-12-31	CN¥2.90 Billion ≈ $424.88 Million	CN¥592.17 Million ≈ $86.65 Million	0.204x	+28.50%
2020-12-31	CN¥2.93 Billion ≈ $428.54 Million	CN¥464.80 Million ≈ $68.01 Million	0.159x	+44.95%
2019-12-31	CN¥2.70 Billion ≈ $395.10 Million	CN¥295.63 Million ≈ $43.26 Million	0.109x	-23.41%
2018-12-31	CN¥2.01 Billion ≈ $294.29 Million	CN¥287.49 Million ≈ $42.07 Million	0.143x	-10.32%
2017-12-31	CN¥1.76 Billion ≈ $257.60 Million	CN¥280.63 Million ≈ $41.06 Million	0.159x	-11.88%
2016-12-31	CN¥1.43 Billion ≈ $208.70 Million	CN¥258.01 Million ≈ $37.75 Million	0.181x	+92.66%
2015-12-31	CN¥1.26 Billion ≈ $185.03 Million	CN¥118.73 Million ≈ $17.37 Million	0.094x	-33.17%
2014-12-31	CN¥773.47 Million ≈ $113.18 Million	CN¥108.68 Million ≈ $15.90 Million	0.141x	+74.44%
2013-12-31	CN¥660.60 Million ≈ $96.67 Million	CN¥53.21 Million ≈ $7.79 Million	0.081x	-13.16%
2012-12-31	CN¥580.03 Million ≈ $84.88 Million	CN¥53.80 Million ≈ $7.87 Million	0.093x	+602.56%
2011-12-31	CN¥543.88 Million ≈ $79.59 Million	CN¥7.18 Million ≈ $1.05 Million	0.013x	-85.46%
2010-12-31	CN¥522.30 Million ≈ $76.43 Million	CN¥47.43 Million ≈ $6.94 Million	0.091x	+16.32%
2009-12-31	CN¥495.41 Million ≈ $72.49 Million	CN¥38.67 Million ≈ $5.66 Million	0.078x	-55.44%
2008-12-31	CN¥148.64 Million ≈ $21.75 Million	CN¥26.04 Million ≈ $3.81 Million	0.175x	-31.56%
2007-12-31	CN¥137.09 Million ≈ $20.06 Million	CN¥35.10 Million ≈ $5.14 Million	0.256x	+5.30%
2006-12-31	CN¥122.00 Million ≈ $17.85 Million	CN¥29.66 Million ≈ $4.34 Million	0.243x	--

About Anhui Anke BioTech Group

SHE:300009 China Biotechnology

Market Cap

$2.16 Billion

CN¥14.77 Billion CNY

Market Cap Rank

#5973 Global

#1280 in China

Share Price

CN¥8.84

Change (1 day)

-1.23%

52-Week Range

CN¥8.24 - CN¥12.30

All Time High

CN¥127.71